2016-03-15T00:00:00.000-04:00
U.S. dermatology,-0.260094
gastrointestinal business,-0.675454
preliminary fourth-quarter revenue,-0.395142
slower growth,-0.260094
softer-than-expected sales,-0.675454
health businesses,0.324038
scrutiny,-0.434847
Executive Michael Pearson,-0.478426
pneumonia,-0.478426
accounting practices,-0.434847
